Scalable Diagnostics Vela Diagnostics offers scalable, open-channel PCR and NGS solutions for infectious disease and oncologic testing, suggesting sales opportunities around laboratories seeking flexible, cost-efficient workflows and integration with existing systems.

Integrated Workflows The combination of real-time PCR and next‑generation sequencing in a single workflow presents a compelling value proposition for labs aiming to streamline operations, reduce turnaround times, and improve data reporting across varied test panels.

Global Reach With a worldwide footprint and a Singapore-based HQ, Vela Diagnostics can coordinate multinational deployments, servicing regional labs and hospital networks seeking consistent molecular diagnostics platforms.

Mid‑Market Focus Company size (51–200 employees) and mid-range revenue position indicate a target for mid-tier labs and regional centers of excellence looking to scale without the heft of large enterprise vendors.

Tech Stack Synergy Existing tech tools (AWS, Jenkins, Jira, Freshdesk) imply readiness for cloud-connected instrument data reporting, software updates, and support ecosystems—sales can emphasize total solution packages and managed services.